Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells

Cytotherapy

Volumn 15, Issue 5, 2013, Pages 598-609

  Castiello, Luciano ^a   Mossoba, Miriam ^b   Viterbo, Antonella ^a   Sabatino, Marianna ^a   Fellowes, Vicki ^b   Foley, Jason E ^b   Winterton, Matthew ^b   Halverson, David C ^b   Civini, Sara ^a   Jin, Ping ^a   Fowler, Daniel H ^b   Stroncek, David F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cell therapy; graft versus host disease; sirolimus; T lymphocytes

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ANTIGEN PRESENTATION; ARTICLE; CELL HYPOXIA; CELL MOTILITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA METABOLISM; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; NORMAL HUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; PRIORITY JOURNAL; SIGNAL NOISE RATIO; STRESS; T LYMPHOCYTE; UBIQUITINATION; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL- AND TISSUE-BASED THERAPY; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; SIROLIMUS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTOME;

EID: 84875713254     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2012.12.008     Document Type: Article

References (48)

1. F. Gorreta, W. Carbone, and D. Barzaghi Genomic profiling: cDNA arrays and oligoarrays Methods Mol Biol 823 2012 89 105
2. P. Jin, T.H. Han, J. Ren, S. Saunders, E. Wang, and F.M. Marincola Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies J Transl Med 8 2010 4
3. J.D. Powell, K.N. Pollizzi, E.B. Heikamp, and M.R. Horton Regulation of immune responses by mTOR Annu Rev Immunol 30 2012 39 68
4. U. Jung, J.E. Foley, A.A. Erdmann, Y. Toda, T. Borenstein, and J. Mariotti Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy Biol Blood Marrow Transplant 12 2006 905 918
5. J.D. Powell, C.G. Lerner, and R.H. Schwartz Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation J Immunol 162 1999 2775 2784
6. M. Battaglia, A. Stabilini, and M.G. Roncarolo Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells Blood 105 2005 4743 4748
7. K. Araki, A.P. Turner, V.O. Shaffer, S. Gangappa, S.A. Keller, and M.F. Bachmann mTOR regulates memory CD8 T-cell differentiation Nature 460 2009 108 112
8. J.E. Foley, U. Jung, A. Miera, T. Borenstein, J. Mariotti, and M. Eckhaus Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism J Immunol 175 2005 5732 5743
9. J. Mariotti, J. Foley, U. Jung, T. Borenstein, N. Kantardzic, and S. Han Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection J Immunol 180 2008 89 105
10. J. Mariotti, J. Foley, K. Ryan, N. Buxhoeveden, V. Kapoor, and S. Amarnath Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway Blood 112 2008 4765 4775
11. S. Amarnath, F.A. Flomerfelt, C.M. Costanzo, J.E. Foley, J. Mariotti, and D.M. Konecki Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD Autophagy 6 4 2010 May 16
12. E.F. Blommaart, J.J. Luiken, P.J. Blommaart, G.M. van Woerkom, and A.J. Meijer Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes J Biol Chem 270 1995 2320 2326
13. S. Amarnath, and D.H. Fowler Harnessing autophagy for adoptive T-cell therapy Immunotherapy 4 2012 1 4
14. M.E. Mossoba, J. Mariotti, X.Y. Yan, F.T. Hakim, D.M. Sabatini, and D. Stroncek T rapa cell clinical products contain a balance of minimally differentiated Th2/Th1 effector cells depleted of Treg cells Blood 116 2010 158 159
15. D.H. Fowler, M.E. Mossoba, F.T. Hakim, R. Kurlander, B.B. Schuver, and M. Sabatino T rapa cell DLI safely balances Th1/Th2 cytokine activation after low-intensity allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 17 Suppl 2011 S157
16. L. Gattinoni, C.A. Klebanoff, D.C. Palmer, C. Wrzesinski, K. Kerstann, and Z. Yu Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells J Clin Invest 115 2005 1616 1626
17. S. Ma, and Y. Dai Principal component analysis based methods in bioinformatics studies Brief Bioinform 12 2011 714 722
18. W. Huang da, B.T. Sherman, Q. Tan, J. Kir, D. Liu, and D. Bryant DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists Nucl Acids Res 35 Web Server issue 2007 W169 W175
19. E.P. Xing, and R.M. Karp CLIFF: clustering of high-dimensional microarray data via iterative feature filtering using normalized cuts Bioinformatics 17 Suppl 1 2001 S306 S315
20. C.L. Liu, I.S. Yu, H.W. Pan, S.W. Lin, and H.C. Hsu L2dtl is essential for cell survival and nuclear division in early mouse embryonic development J Biol Chem 282 2007 1109 1118
21. G. Whelan, E. Kreidl, G. Wutz, A. Egner, J.M. Peters, and G. Eichele Cohesin acetyltransferase Esco2 is a cell viability factor and is required for cohesion in pericentric heterochromatin Embo J 31 2011 71 82
22. M.M. Dawlaty, L. Malureanu, K.B. Jeganathan, E. Kao, C. Sustmann, and S. Tahk Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha Cell 133 2008 103 115
23. V.I. Bunik, and D. Degtyarev Structure-function relationships in the 2-oxo acid dehydrogenase family: substrate-specific signatures and functional predictions for the 2-oxoglutarate dehydrogenase-like proteins Proteins 71 2008 874 890
24. M. Dabrowska, M. Skoneczny, and W. Rode Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells Tumour Biol 32 2011 965 976
25. G. Fantuzzi, and C.A. Dinarello Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1) J Clin Immunol 19 1999 1 11
26. J. Yun, S.H. Song, J. Park, H.P. Kim, Y.K. Yoon, and K.H. Lee Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers Lab Invest 92 2012 1033 1044
27. T. Vogl, K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, and M.A. van Zoelen Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock Nat Med 13 2007 1042 1049
28. C. Jin, and R.A. Flavell Molecular mechanism of NLRP3 inflammasome activation J Clin Immunol 30 2010 628 631
29. J.L. Owen, M.F. Criscitiello, S. Libreros, R. Garcia-Areas, K. Guthrie, and M. Torroella-Kouri Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice Cell Immunol 270 2011 172 182
30. W.E. Paul, and J. Zhu How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10 2010 225 235
31. J. Mitchell, V. Dimov, and R.G. Townley IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease Curr Opin Investig Drugs 11 2010 527 534
32. M. Kashiwada, S.L. Cassel, J.D. Colgan, and P.B. Rothman NFIL3/E4BP4 controls type 2 T helper cell cytokine expression Embo J 30 2011 2071 2082
33. L. Cimmino, G.A. Martins, J. Liao, E. Magnusdottir, G. Grunig, and R.K. Perez Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression J Immunol 181 2008 2338 2347
34. S. Boisson-Dupuis, J. El Baghdadi, N. Parvaneh, A. Bousfiha, J. Bustamante, and J. Feinberg IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey PLoS One 6 2011 e18524
35. K.J. Jun, M.J. Lee, D.C. Shin, M.Y. Woo, K. Kim, and S. Park Identification of CCL1 as a gene differentially expressed in CD4 T cells expressing TIM-3 Immune Netw 11 2011 203 209
36. T.L. Geiger, and S. Tauro Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function Hum Immunol 73 2012 232 239
37. D. Bruder, M. Probst-Kepper, A.M. Westendorf, R. Geffers, S. Beissert, and K. Loser Neuropilin-1: a surface marker of regulatory T cells Eur J Immunol 34 2004 623 630
38. D.J. Zabransky, C.J. Nirschl, N.M. Durham, B.V. Park, C.M. Ceccato, and T.C. Bruno Phenotypic and functional properties of Helios+ regulatory T cells PLoS One 7 2012 e34547
39. C. Vogel, A. Bauer, M. Wiesnet, K.T. Preissner, W. Schaper, and H.H. Marti Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway J Cell Physiol 212 2007 236 243
40. L. Shen, J. Guo, C. Santos-Berrios, and M.X. Wu Distinct domains for anti- and pro-apoptotic activities of IEX-1 J Biol Chem 281 2006 15304 15311
41. M. Nagel, E. Tahinci, K. Symes, and R. Winklbauer Guidance of mesoderm cell migration in the Xenopus gastrula requires PDGF signaling Development 131 2004 2727 2736
42. R. Harmancey, J.M. Senard, A. Pathak, F. Desmoulin, C. Claparols, and P. Rouet The vasoactive peptide adrenomedullin is secreted by adipocytes and inhibits lipolysis through NO-mediated beta-adrenergic agonist oxidation FASEB J 19 2005 1045 1047
43. T. Shimazu, R. Iida, Q. Zhang, R.S. Welner, K.L. Medina, and J. Alberola-Lla CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential Blood 119 2012 4889 4897
44. S.M. Fu, U.S. Deshmukh, and F. Gaskin Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR J Autoimmun 37 2011 104 112
45. A.K. Witkiewicz, K.E. Knudsen, A.P. Dicker, and E.S. Knudsen The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments Cell Cycle 10 2011 2497 2503
46. P.H. Sun, L.M. Zhu, M.M. Qiao, Y.P. Zhang, S.H. Jiang, and Y.L. Wu The XAF1 tumor suppressor induces autophagic cell death via upregulation of Beclin-1 and inhibition of Akt pathway Cancer Lett 310 2011 170 180
47. M.A. Weinreich, K. Takada, C. Skon, S.L. Reiner, S.C. Jameson, and K.A. Hogquist KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors Immunity 31 2009 122 130
48. M. Pesu, A. Laurence, N. Kishore, S.H. Zwillich, G. Chan, and J.J. O'Shea Therapeutic targeting of Janus kinases Immunol Rev 223 2008 132 142